The Gross Margin of AptaBio Therapeutics Inc (293780.KQ) is 8.53%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 8.53% |
2023-12-31 | 24.24% |
2022-12-31 | 76.94% |